摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氟-2,3-二氢-1H-吲哚盐酸盐 | 552866-98-5

中文名称
4-氟-2,3-二氢-1H-吲哚盐酸盐
中文别名
4-氟吲哚啉;4-氟-2,3-二氢-1H-吲哚
英文名称
4-fluoroindoline
英文别名
4-fluoro-2,3-dihydro-1H-indole
4-氟-2,3-二氢-1H-吲哚盐酸盐化学式
CAS
552866-98-5
化学式
C8H8FN
mdl
MFCD07371634
分子量
137.157
InChiKey
CMQOXZRRFDMQKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    215.7±29.0 °C(Predicted)
  • 密度:
    1.154±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存储条件:2-8℃,请密封保存并在干燥处存放。

SDS

SDS:1f3f945cba9ec72a383a03e5f5770fc9
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Fluoro-2,3-dihydro-1H-indole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
P273: Avoid release to the environment
P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician

Section 3. Composition/information on ingredients.
Ingredient name: 4-Fluoro-2,3-dihydro-1H-indole
CAS number: 552866-98-5

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H8FN
Molecular weight: 137.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (4-Fluoro-2,3-dihydro-1H-indole)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE 5-SULFAMOYL-2-HYDROXYBENZAMIDE
    申请人:GLAXOSMITHKLINE IP DEV LTD
    公开号:WO2017153952A1
    公开(公告)日:2017-09-14
    The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    本发明涉及取代水杨酰胺衍生物。具体而言,本发明涉及根据公式(I)的化合物:其中R、R1和R2如本文所述,或其药用可接受的盐。本发明的化合物是CD73的抑制剂,可用于治疗癌症、前癌症综合症以及与CD73抑制相关的疾病,例如艾滋病、治疗HIV、自身免疫疾病、感染、动脉粥样硬化和缺血再灌注损伤。因此,本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制CD73活性和治疗与之相关的疾病的方法。
  • Sustainable Radical Cascades to Synthesize Difluoroalkylated Pyrrolo[1,2-<i>a</i>]indoles
    作者:Honggui Huang、Menglin Yu、Xiaolong Su、Peng Guo、Jia Zhao、Jiabing Zhou、Yi Li
    DOI:10.1021/acs.joc.7b03017
    日期:2018.2.16
    We disclose herein a photocatalytic difluoroalkylation and cyclization cascade reaction of N-(but-2-enoyl)indoles with broad substrate scopes in up to 90% isolated yield. This method provides sustainable and efficient access to synthesize difluoroalkylated pyrrolo[1,2-a]indoles with a quaternary carbon center under mild conditions.
    我们在此公开了N-(丁-2-烯酰基)吲哚具有宽的底物范围的光催化二氟烷基化和环化级联反应,其分离产率高达90%。该方法提供了在温和条件下可持续有效地合成具有季碳中心的二氟烷基化吡咯并[1,2- a ]吲哚的方法。
  • New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
    作者:Dong-Jin Hwang、Yali He、Suriyan Ponnusamy、Michael L. Mohler、Thirumagal Thiyagarajan、Iain J. McEwan、Ramesh Narayanan、Duane D. Miller
    DOI:10.1021/acs.jmedchem.8b00973
    日期:2019.1.24
    propanamides (series II and III) were discovered as selective androgen receptor degraders (SARDs). Initial studies of androgen receptor (AR) antagonist (1) and agonist (2) propanamides yielded a tertiary aniline (3) with novel SARD activity but poor metabolic stability. Cyclization to II and III produced submicromolar AR antagonism and protein degradation selective to AR and AR splice variant (AR SV). II and
    在寻找晚期前列腺癌(PCs)的小分子治疗方法的过程中,发现了一系列新颖的吲哚基和吲哚基丙酰胺(II和III系列)作为选择性雄激素受体降解剂(SARDs)。对雄激素受体(AR)拮抗剂(1)和激动剂(2)丙酰胺的初步研究产生了具有新型SARD活性但代谢稳定性较差的叔苯胺(3)。环化至II和III产生亚微摩尔的AR拮抗作用,并对AR和AR剪接变体(AR SV)产生选择性的蛋白质降解。二和三维持对enzalutamide耐药(Enz-R)突变的ARs和PC细胞的效力,并且对Enz-R异种移植物有效,表明它们具有治疗晚期PCs的潜力。新型SARD的设计,合成和生物学活性,可潜在地用于治疗各种PC,包括去势抵抗性,Enz-R和/或AR SV依赖性的晚期PC,这些已知PC通常无法用已知的激素疗法治疗讨论。
  • Synthesis and Photophysical Study of Heteropolycyclic and Carbazole Motif: Nickel-Catalyzed Chelate-Assisted Cascade C–H Activations/Annulations
    作者:Namrata Prusty、Shyam Kumar Banjare、Smruti Ranjan Mohanty、Tanmayee Nanda、Komal Yadav、Ponneri C. Ravikumar
    DOI:10.1021/acs.orglett.1c03234
    日期:2021.12.3
    through sequential C–H bond activations has been described. Regioselective indole C2/C3 functionalization has been achieved in the presence of indole C7-H, which is quite challenging. In addition, this approach also gives easy access to building a heteropolycyclic motif through C6/C7 C–H functionalization of indoline. This methodology is not limited to aromatic internal alkynes as coupling partners; aliphatic
    本文描述了镍催化通过连续 C-H 键活化合成聚芳基咔唑。区域选择性吲哚 C2/C3 功能化已经在吲哚 C7-H 的存在下实现,这是非常具有挑战性的。此外,这种方法还可以通过二氢吲哚的 C6/C7 C-H 功能化轻松构建杂多环基序。这种方法不仅限于芳香族内炔作为偶联伙伴;脂肪族炔烃也表现出良好的耐受性。值得注意的是,在优化过程中,已经观察到碘化钠作为添加剂的催化增强。我们还研究了这些高度共轭分子的光物理特性。
  • [EN] N-SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES<br/>[FR] DERIVES DE PIPERIDINE ET DE PIPERAZINE N-SUBSTITUES
    申请人:WARNER LAMBERT CO
    公开号:WO2005066165A1
    公开(公告)日:2005-07-21
    This invention relates to compounds of the formula 1 wherein R1, R2, R7, R8, R9, U, V, Z, A, W, X, M, E, L, T and D are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.
    这项发明涉及式1的化合物,其中R1、R2、R7、R8、R9、U、V、Z、A、W、X、M、E、L、T和D的定义如规范中所述,包含它们的药物组合物以及它们在治疗中枢神经系统和其他疾病中的用途。
查看更多

同类化合物

(Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (R)-(+)-5'-苄氧基卡维地洛 (R)-卡洛芬 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (3Z)-3-(1H-咪唑-5-基亚甲基)-5-甲氧基-1H-吲哚-2-酮 (3Z)-3-[[[4-(二甲基氨基)苯基]亚甲基]-1H-吲哚-2-酮 (3R)-(-)-3-(1-甲基吲哚-3-基)丁酸甲酯 (3-氯-4,5-二氢-1,2-恶唑-5-基)(1,3-二氧代-1,3-二氢-2H-异吲哚-2-基)乙酸 齐多美辛 鸭脚树叶碱 鸭脚木碱,鸡骨常山碱 鲜麦得新糖 高氯酸1,1’-二(十六烷基)-3,3,3’,3’-四甲基吲哚碳菁 马鲁司特 马来酸阿洛司琼 马来酸替加色罗 顺式-ent-他达拉非 顺式-1,3,4,4a,5,9b-六氢-2H-吡啶并[4,3-b]吲哚-2-甲酸乙酯 顺式-(+-)-3,4-二氢-8-氯-4'-甲基-4-(甲基氨基)-螺(苯并(cd)吲哚-5(1H),2'(5'H)-呋喃)-5'-酮 靛红联二甲酚 靛红磺酸钠 靛红磺酸 靛红乙烯硫代缩酮 靛红-7-甲酸甲酯 靛红-5-磺酸钠 靛红-5-磺酸 靛红-5-硫酸钠盐二水 靛红-5-甲酸甲酯 靛红 靛玉红3'-单肟5-磺酸 靛玉红-3'-单肟 靛玉红 青色素3联己酸染料,钾盐 雷马曲班 雷莫司琼杂质13 雷莫司琼杂质12 雷莫司琼杂质 雷替尼卜定 雄甾-1,4-二烯-3,17-二酮 阿霉素的代谢产物盐酸盐 阿贝卡尔 阿西美辛叔丁基酯 阿西美辛 阿莫曲普坦杂质1 阿莫曲普坦 阿莫曲坦二聚体杂质 阿莫曲坦 阿洛司琼杂质